A randomised controlled multicentre trial of treatments for adloescent anorexia nervosa including assessment of cost-effectiveness and patient acceptability - the TOuCAN trial

作者：Gowers S G^*; Clark A F; Roberts C; Byford S; Barrett S; Griffiths A; Edwards V; Bryan C; Smethurst N; Rowlands L; Roots P

来源：Health Technology Assessment, 2010, 14(15): 1-+.

Anorexia nervosa (AN) is a complex eating disorder, generally developing in adolescence or young adulthood but sometimes in late childhood. It is relatively rare at 12 years, but the prevalence rises with age, reportedly reaching about one in 200 adolescent girls at 16 years. The highest incidence rates are for females aged 15-19 years, who represent approximately 40% of all identified! cases.' Incidence and prevalence rates of AN in males are more rarely reported, but it has been noted that where they are, the female to male ratio is around 11:1 overall(1) but it appears to be somewhat lower in adolescents,(2) with a more equal sex ratio at the younger end of the spectrum.

• 出版日期2010-3